Mazda Production and Sales Results for January 2023

HIROSHIMA, Japan, Feb 28, 2023 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation’s production and sales results for January 2023 are summarized below.

I. Production

1. Domestic Production

Mazda’s domestic production volume in January 2023 decreased 7.2% year on year due to decreased production of passenger vehicles.

[Domestic production of key models in January 2023]
CX-5:24,670 units
(down 26.7% year on year)
CX-60:8,490 units
MAZDA3:7,485 units
(down 24.1%)

2. Overseas Production

Mazda’s overseas production volume in January 2023 decreased 3.6% year on year due to decreased production of passenger vehicles.

[Overseas production of key models in January 2023]
CX-30:13,248 units
(down 1.5% year on year)
MAZDA3:5,283 units
(down 60.4%)
CX-50:4,438 units
(up 3313.8%)

II. Domestic Sales

Mazda’s domestic sales volume in January 2023 increased 22.7% year on year due to increased sales of passenger and commercial vehicles.

Mazda’s registered vehicle market share was 5.5% (up 0.4 points year on year), with a 2.0% share of the micro-mini segment (unchanged year-on-year) and a 4.1% total market share (up 0.2 points).

[Domestic sales of key models in January 2023]
CX-60:3,016 units
MAZDA2:2,003 units
(up 9.9%)
CX-30:1,634 units
(down 5.2%)

III. Exports

Mazda’s export volume in January 2023 increased 5.9% year on year due to increased shipments to Europe and other regions.

[Exports of key models in January 2023]
CX-5:26,631 units
(up 3.2% year on year)
MAZDA3:6,470 units
(up 3.9%)
CX-9:6,022 units
(up 27.2%)

IV. Global Sales

Mazda’s global sales volume in January 2023 decreased 7.4% year on year due to decreased sales in China.

[Global sales of key models in January 2023]
CX-5:25,391 units
(down 22.1% year on year)
CX-30:13,222 units
(down 2.1%)
MAZDA3:11,634 units
(down 49.9%)

For more information, visit https://newsroom.mazda.com/en/publicity/release/2023/202302/230227a.html.

Copyright 2023 JCN Newswire. All rights reserved. (via SEAPRWire)

Previous post Teledyne e2v 推出一站式光學模組 一百五十萬像素版本的Optimom 用於快速和簡單地開發視覺系統
Next post Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration